Eagle Meds Services
OPZELURA (ruxolitinib)
Available to sourceHuman Prescription DrugOncology & Specialty

OPZELURA (ruxolitinib)

Active ingredients · Ruxolitinib Phosphate

15 mg/g · Cream
By Incyte Corporation
NDC
50881-007
Route
Topical
Therapeutic class
Janus Kinase Inhibitor , Janus Kinase Inhibitors [MoA], Kinase Inhibitor
Marketing category
NDA

Additional information

Full prescribing information for this product is available on request. Submit a sourcing request and our team will share lot details, dating, and current pricing.

Request this medication

Send a request and we'll respond with availability, lot details, and pricing within 2 business hours.

Requesting
OPZELURA (ruxolitinib)
NDC 50881-007
(980) 480-3410 requests@eaglemedsservices.com

Related in Oncology & Specialty

See all →
Verzenio (abemaciclib)

Verzenio (abemaciclib)

50 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)

Verzenio (abemaciclib)

200 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)

Verzenio (abemaciclib)

100 mg/1 · Tablet
Eli Lilly and Company
Available to source
Verzenio (abemaciclib)

Verzenio (abemaciclib)

150 mg/1 · Tablet
Eli Lilly and Company
Available to source